Quantcast

Latest Bioethics Stories

2014-06-28 08:21:00

- TAS-102 demonstrated a statistically significant improvement in overall survival and progression-free survival - BARCELONA, Spain and PRINCETON, N.J., June 28, 2014 /PRNewswire/

2014-06-23 08:27:43

Gelesis100 2.25 g demonstrated significant weight loss in a double-blind, placebo-controlled, parallel-group 12-week study of overweight and obese subjects, including prediabetics BOSTON,

2014-06-17 08:30:10

MOMENCE, Ill., June 17, 2014 /PRNewswire/ -- FutureCeuticals, Inc.

2014-06-05 23:01:58

Barbara and Edward Netter awarded prestigious distinction by the American Society of Gene and Cell Therapy. Washington, DC (PRWEB) June 05, 2014 Barbara

2014-06-01 08:20:11

-Study appears in June 1 online edition- NORTHBROOK, Ill. and SAN FRANCISCO, JUNE 1, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S.

2014-05-27 15:22:17

For the first time researchers have succeeded in altering HIV virus particles so that they can simultaneously, as it were, 'cut and paste' in our genome via biological processes.

2014-05-23 16:23:57

WASHINGTON, May 23, 2014 /PRNewswire-USNewswire/ -- "The latest Gallup polling on abortion portrays a false dichotomy between 'prochoice' and 'prolife,'" said Jon O'Brien, president of Catholics

2014-05-22 23:03:22

Transparency Market Research added a new report "Global Gene Therapy Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.

2014-05-20 23:11:54

New York Times Best Seller 'You Are the Placebo' is an insightful book that shows how much power our mind has, and how meditation can help us to overcome various difficulties in life.

2014-05-20 16:27:10

- Pooled Efficacy Analyses from Phase 3 ASCEND and CAPACITY Studies Presented at 2014 American Thoracic Society Meeting - SAN DIEGO, May 20, 2014 /PRNewswire/ -- InterMune, Inc.


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »